The correlation between Sirt1 and ACE2 also reinforces the hypothesis that Sirt1 activity could be used as a biomarker to better differentiate the patients with different HF phenotypes, especially to separate HFmrEF/HFrEF from HFpEF. This evidence concerns the gene ACE2 and hydrops fetalis.